Novo Nordisk A/S (ADR) - NVO - Financial Statement Analysis
All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.
In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.
Financial statement analysis updated: May 26, 2013
Novo Nordisk A/S (ADR) - SIC # 2834
|Ticker||Exchange||SIC #||Website||Latest Ticker|
|NVO||New York||2834||http://www.novonordisk.com||168.64 -0.28|
Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Novo Nordisk A/S (ADR)
Should These Drug Companies Pay a Dividend? - May 24th, 2013 7:23 am
Stock Upgrades: Changing Tides Makes Procter & Gamble a Better Bet - May 24th, 2013 7:20 am
The Coming Diabetes Wars - May 23rd, 2013 9:48 am
Pricing A Highly Probable Takeover Of MannKind - May 22nd, 2013 3:28 am
Positive Data on Novo Nordisk's N9-GP - May 21st, 2013 2:10 pm
View All Current Headlines >>